Revenue performance remains highly erratic, with net profit margins compressing to 7.4% in 2025Q4 from 15.3% in 2025Q2, suggesting challenges in scaling profitability alongside top-line expansion.
| Sales/Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | - | - | - | - | - | - | - | - | - | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 2.71B | 1.29B | 1.69B | 862.3M | 825.3M | 757.53M | 549.19M | 384.47M | 317.9M | 328.31M | 345.89M | 367.97M | 0 |
| Gross Margin % | 74.72% | 44.47% | 71.97% | 73.37% | 96.9% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | - |
| Gross Profit Growth % | 110.7% | -23.96% | 96.32% | 4.48% | 8.95% | 37.93% | 42.85% | 20.94% | -3.17% | -5.08% | -6% | - | - |
| Operating Expenses | 1.55B | 450.9M | 798.8M | 223.1M | 144.8M | 700.95M | 541.19M | 339.23M | 292.66M | 301.99M | 323.17M | 352.87M | 364.87M |
| OpEx % of Revenue | 42.74% | 15.58% | 33.96% | 18.98% | 17% | 92.53% | 98.54% | 88.23% | 92.06% | 91.98% | 93.43% | 95.9% | 101.9% |
| Selling, General & Admin | 0 | 247.1M | 798.8M | 120.1M | 82.5M | 276.9M | 211.92M | 0 | 0 | 0 | 0 | 40K | 1.43M |
| SG&A % of Revenue | - | 8.54% | 33.96% | 10.22% | 9.69% | 36.55% | 38.59% | - | - | - | - | 0.01% | 0.4% |
| Research & Development | - | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 1.16B | 836.3M | 683.5M | 270.5M | 68.6M | 56.58M | 12.23M | 45.24M | 25.24M | 26.33M | 22.73M | 15.1M | -9.11M |
| Operating Margin % | 31.98% | 28.89% | 29.06% | 23.02% | 8.05% | 7.47% | 2.23% | 11.77% | 7.94% | 8.02% | 6.57% | 4.1% | -2.54% |
| Operating Income Growth % | 38.8% | 22.36% | 152.68% | 294.31% | 21.25% | 362.59% | -72.97% | 79.24% | -4.12% | 15.84% | 50.5% | 265.73% | - |
| EBITDA | 1.2B | 865.1M | 705.4M | 284.3M | 78.9M | 20.16M | 0 | 45.24M | 25.24M | 26.33M | 22.73M | 15.1M | 0 |
| EBITDA Margin % | 32.97% | 29.88% | 29.99% | 24.19% | 9.26% | 2.66% | - | 11.77% | 7.94% | 8.02% | 6.57% | 4.1% | - |
| EBITDA Growth % | 38.35% | 22.64% | 148.12% | 260.33% | 291.47% | - | -100% | 79.24% | -4.12% | 15.84% | 50.5% | - | - |
| D&A (Non-Cash Add-back) | 36.1M | 28.8M | 21.9M | 13.8M | 10.3M | -36.42M | -12.23M | 0 | 0 | 0 | 0 | 0 | 9.11M |
| EBIT | 1.17B | 833.9M | 683.5M | 270.5M | 96.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Interest Income | 152.6M | -546.8M | -475.6M | -169.1M | -29.7M | 20.46M | 38.63M | 7.44M | 4.17M | 1.84M | 554K | 399K | 0 |
| Interest Income | 912.8M | -8.7M | -5.4M | 0 | 23.1M | 20.46M | 38.63M | 0 | 0 | 0 | 0 | 0 | 620K |
| Interest Expense | 760.2M | 538.1M | 470.2M | 165M | 26.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | 411.6M | 295.8M | 196.5M | 121.6M | 69.9M | 54.98M | 46.63M | 13.43M | 25.45M | 27.01M | 17.62M | 22.63M | -6.19M |
| Pretax Margin % | 11.34% | 10.22% | 8.35% | 10.35% | 8.21% | 7.26% | 8.49% | 3.49% | 8.01% | 8.23% | 5.09% | 6.15% | -1.73% |
| Income Tax | 103.7M | 77.8M | 55.2M | 23.4M | 13.4M | 11.16M | 10.23M | 3.28M | 7.95M | 6.51M | 25K | 4.75M | 1.08M |
| Effective Tax Rate % | 25.19% | 26.3% | 28.09% | 19.24% | 19.17% | 20.3% | 21.95% | 24.42% | 31.24% | 24.12% | 0.14% | 21.02% | -17.49% |
| Net Income | 308.2M | 218M | 128M | 91.6M | 56.5M | 43.82M | 36.39M | 10.15M | 17.5M | 20.49M | 17.64M | 17.87M | -5.11M |
| Net Margin % | 8.49% | 7.53% | 5.44% | 7.79% | 6.63% | 5.79% | 6.63% | 2.64% | 5.5% | 6.24% | 5.1% | 4.86% | -1.43% |
| Net Income Growth % | 41.38% | 70.31% | 39.74% | 62.12% | 28.93% | 20.42% | 258.47% | -41.99% | -14.6% | 16.14% | -1.27% | 450% | - |
| Net Income (Continuing) | 307.9M | 218M | 141.3M | 98.5M | 56.5M | 43.82M | 36.39M | 10.15M | 17.5M | 20.49M | 17.64M | 17.87M | 0 |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 3.87 | 2.72 | 1.82 | 1.36 | 0.80 | 0.72 | 0.60 | 0.17 | 0.29 | 0.34 | 0.29 | 0.29 | -0.08 |
| EPS Growth % | 42.28% | 49.45% | 33.82% | 70% | 11.11% | 20% | 252.94% | -41.38% | -14.71% | 17.24% | 0% | 444.42% | - |
| EPS (Basic) | 4.13 | 2.96 | 1.94 | 1.29 | 0.80 | 0.72 | 0.60 | 0.17 | 0.29 | 0.34 | 0.29 | 0.29 | -0.08 |
| Diluted Shares Outstanding | 76.13M | 75.28M | 72.22M | 70.82M | 70.82M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M |
| Basic Shares Outstanding | 71.35M | 80.15M | 72.22M | 70.82M | 70.82M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M | 60.63M |
| Dividend Payout Ratio | - | 35.37% | 45.55% | 7.21% | 35.4% | 41.52% | - | - | 114.29% | 97.6% | - | - | - |
Commodity market volatility exposure
As reported in recent financial statements, Marex Group's revenue trajectory exhibits significant quarter-over-quarter fluctuations, reaching $3.1B in 2025Q4 compared to $500.1M in 2025Q2, suggesting that the firm's top-line performance is heavily tethered to episodic commodity market volatility rather than consistent, linear organic growth.
The extreme variance in quarterly revenue figures implies that Marex's business model remains highly sensitive to external market conditions and trading volumes. Investors should monitor whether this volatility represents a structural feature of their market-making segment or if it indicates inconsistent execution across their diversified service offerings.
Based on the provided income statement data, Marex's net profit margin has experienced notable compression, falling to 7.4% in 2025Q4 from 15.3% in 2025Q2, which suggests that the firm is struggling to translate top-line revenue growth into meaningful bottom-line profitability as it scales its operations.
The divergence between gross profit expansion and net income contraction points toward rising operational overhead or increased interest expenses associated with the firm's capital-intensive clearing activities. This trend warrants further investigation into whether the firm's recent acquisitions are creating long-term synergies or merely adding layers of costly complexity to the income statement.
According to the historical income statement data, Marex's operating margin has swung wildly from -16.2% in 2023Q4 to 52.9% in 2024Q2, indicating that the firm has yet to achieve a stable or predictable level of operating leverage despite its significant expansion in the commodity clearing space.
The lack of consistent operating leverage suggests that the firm's cost structure is not yet optimized for its current scale, potentially due to the integration of recent M&A activity. Analysts should scrutinize the firm's ability to control SG&A expenses, which appear to fluctuate significantly and may be masking underlying inefficiencies in the core brokerage business.
As indicated by the reported figures, Marex's EPS growth has been erratic, with a 33.8% decline in 2025Q4 following a 93.1% surge in 2024Q4, suggesting that reported net income is heavily influenced by non-operating items and mark-to-market valuations inherent in their principal trading and market-making segments.
The presence of stock-based compensation and the inherent volatility of principal trading gains make it difficult to ascertain the firm's true recurring earnings power. Investors should be cautious of relying on headline EPS figures, as they may not accurately reflect the underlying cash-generating capability of the firm's core clearing and agency services.
Quick answers to the most common questions about buying MRX stock.
Marex Group plc Ordinary Shares (MRX) is profitable, generating $308.2M in net income for the fiscal year ending 2025 with a net profit margin of 8.5%.
Marex Group plc Ordinary Shares (MRX) reported an operating income of $1.16B, resulting in an operating profit margin of 32.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Marex Group plc Ordinary Shares (MRX) generated $2.71B in gross profit for the year, representing a gross profit margin of 74.7%. This demonstrates the company's core pricing power and production efficiency.